Houston Clinical Trials

Houston, Texas 77401

0 studies enrolling now · 12 studies all time

What they study most

ADHD, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), Treatment Resistant Depression

Studies at this site

• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression — Recruiting now
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment — Stopped early
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) — Completed
• Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD — Completed
• The Efficacy and Safety of PRC-063 in Adult ADHD Patients — Completed
• AR08 for Treatment of ADHD in Children — Completed
• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD — Completed
• PRC-063 in Adolescent ADHD — Completed